We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Omeros Corporation today reported that clinical trial site activation for enrollment is underway for the company's Phase 3 program evaluating zaltenibart in paroxysmal nocturnal hemoglobinuria (PNH).
After hours: March 24 at 6:08:06 PM EDT Vertex Baseline Delta ...
Pre-Market: 5:46:14 a.m. EDT Loading Chart for NRG ...
DGXX Digi Power X Inc.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback